Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma

Clinical trial NCT03590574 · TERMINATED

Trial details

NCT number: NCT03590574
Sponsor: Autolus Limited
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

T Cell Non-Hodgkin Lymphoma Peripheral T-Cell Lymphoma, Not Otherwise Specified Angioimmunoblastic T-cell Lymphoma Anaplastic Large Cell Lymphoma

Start date: 2018-08-30
Primary completion: 2024-12-12
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.